EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical characterization of Collagen XII ‐related disease caused by biallelic COL12A1 variants

Riley M McCarty, Dimah Saade, Pinki Munot, Chamindra G Laverty, Hailey Pinz, Yaqun Zou, Meghan McAnally, Pomi Yun, Cuixia Tian, Ying Hu, Lucy Feng, Rahul Phadke und 17 weitere

Annals of Clinical and Translational Neurology · 2025-03 · 12 (3) · 602-614

DOI: 10.1002/acn3.52225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 09.02.2025. Verfasst von Riley M McCarty und 28 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health…. Hauptthemen laut MEDLINE: Collagen Type XII, Ehlers-Danlos Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coalition to Cure Calpain 3, Genzyme, Sanofi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

While there have been several reports of patients with dominantly acting COL12A1 variants, few cases of the more severe recessive Collagen XII‐related disorders have previously been documented.

Methods

We present detailed clinical, immunocytochemical, and imaging data on eight additional patients from seven families with biallelic pathogenic variants in COL12A1 .

Results

All patients presented with a consistent constellation of congenital onset clinical features: hypotonia, dysmorphic features, most notably gingival hypertrophy, prominent distal joint hyperlaxity, with co‐occurring contractures of large joints, and variable muscle involvement, evident both clinically and on muscle imaging. Five patients presented with a severe congenital phenotype manifesting with profound weakness, significantly delayed or minimal attainment of motor milestones, respiratory insufficiency, and feeding difficulties. Three patients presented with mild‐to‐moderate muscle weakness and delayed milestones but were able to achieve independent ambulation. Patients were found to have biallelic loss‐of‐function COL12A1 variants, except for one family (p.I1393Ffs*11/p.A1110D). Consistent with the variable clinical spectrum, in vitro immunocytochemistry analysis in fibroblasts ranged from complete absence of Collagen XII expression in a patient with severe disease, to a mild reduction in a patient with milder disease.

Interpretation

Here we characterize the clinical presentation, muscle imaging, and dermal fibroblast immunostaining findings associated with biallelic variants in COL12A1, further establishing COL12A1 as a recessive myopathic Ehlers–Danlos syndrome (mEDS) gene, and expanding the clinical spectrum to include a milder EDS phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Collagen Type XIIEhlers-Danlos SyndromeAdolescentAdultChildChild, PreschoolFemaleHumansInfantMalePhenotype

Substanzen

COL12A1 protein, humanCollagen Type XII

Autor:innen und Institutionen

  • Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Department of Pediatrics, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
  • The Dubowitz Neuromuscular Centre, Great Ormond Street Institute of Child Health, London, UK.
  • Department of Neurosciences, University of California San Diego, San Diego, California, USA.
  • Division of Medical Genetics, Saint Louis University, St. Louis, Missouri, USA.
  • Division of Neurology, Cincinnati Children's Hospital Medical Center & Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.

ORCID-Profile: A Reghan Foley, Sandra Donkervoort, Carsten G Bönnemann

Förderung

  • Coalition to Cure Calpain 3
  • Genzyme
  • Sanofi
  • NINDS NIH HHS
  • LGMD2I Research Fund
  • LGMD2D Foundation and Kurt+Peter Foundation
  • Muscular Dystrophy UK
  • NIH

Zitieren

APA

McCarty, R. M., Saade, D., Munot, P., Laverty, C. G., Pinz, H., Zou, Y., McAnally, M., Yun, P., Tian, C., Hu, Y., Feng, L., Phadke, R., Ceulemans, S., Magoulas, P., Skalsky, A. J., Friedman, J. R., Braddock, S. R., Neuhaus, S. B., Malicki, D. M., …, & Bönnemann, C. G. (2025). Clinical characterization of Collagen XII ‐related disease caused by biallelic COL12A1 variants. Annals of Clinical and Translational Neurology, 12(3), 602-614. https://doi.org/10.1002/acn3.52225

Vancouver

McCarty RM, Saade D, Munot P, Laverty CG, Pinz H, Zou Y, et al. Clinical characterization of Collagen XII ‐related disease caused by biallelic COL12A1 variants. Annals of Clinical and Translational Neurology. 2025;12(3):602-614. doi:10.1002/acn3.52225

BibTeX
@article{McCarty2025,
  author = {McCarty, Riley M and Saade, Dimah and Munot, Pinki and Laverty, Chamindra G and Pinz, Hailey and Zou, Yaqun and McAnally, Meghan and Yun, Pomi and Tian, Cuixia and Hu, Ying and Feng, Lucy and Phadke, Rahul and Ceulemans, Sophia and Magoulas, Pilar and Skalsky, Andrew J and Friedman, Jennifer R and Braddock, Stephen R and Neuhaus, Sarah B and Malicki, Denise M and Bainbridge, Matthew N and Nahas, Shareef and Dimmock, David P and Kingsmore, Stephen F and Lotze, Timothy E and Foley, A Reghan and Muntoni, Francesco and Straub, Volker and Donkervoort, Sandra and Bönnemann, Carsten G},
  title = {Clinical characterization of Collagen XII ‐related disease caused by biallelic COL12A1 variants},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  volume = {12},
  number = {3},
  pages = {602--614},
  doi = {10.1002/acn3.52225}
}
Kostenlos starten →